Meprobamate
Meprobamate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Meprobamate; Generic name: MEPROBAMATE; Manufacturer: Cipla USA Inc..
| Brand name | Meprobamate |
|---|---|
| Generic name | MEPROBAMATE |
| Manufacturer | Cipla USA Inc. |
| Used for | INDICATIONS AND USAGE Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety.Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic. The effectiveness of meprobamate tablets in long-term use, that is,more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient. |
| Dosage | DOSAGE AND ADMINISTRATION Meprobamate Tablets USP: The usual adult daily dosage is 1200 mg to 1600 mg, in three or four divided doses; a daily dosage above 2400mg is not recommended. The usual daily dosage for children ages six to twelve years is 200 mg to 600 mg, in two or three divided doses. Not recommended for children under age 6 (see Usage in Children). |
| Warnings | WARNINGS Drug Dependence Physical dependence, psychological dependence, and abuse have occurred. When chronic intoxication from prolonged use occurs, it usually involves ingestion of greater than recommended doses and is manifested by ataxia, slurred speech, and vertigo. Therefore, careful supervision of dose and amounts prescribed is advised, as well as avoidance of prolonged administration, especially for alcoholics and other patients with a known propensity for taking excessive quantities of |
| Active ingredient(s) | MEPROBAMATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17d814e2-b277-4dce-8615-e7fd7cab773f |